Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review
Authors:
- Zara KhizerZKZara Khizer
- Amina SadiaASAmina Sadia
- Raman SharmaRSRaman Sharma
- Samia FarhajSFSamia Farhaj
- Jorabar Singh NirwanJNJorabar Singh Nirwan
- Pratibha G. KakadiaPKPratibha G. Kakadia
- Talib HussainTHTalib Hussain
- Abid Mehmood YousafAYAbid Mehmood Yousaf
- Yasser ShahzadYSYasser Shahzad
- Barbara R. ConwayBarbara R. Conway
- Muhammad Usman GhoriMuhammad Usman Ghori
Open Access
- 26 April 2021
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (5) , 409
Abstract
Overactive bladder syndrome (OAB) is characterised by urgency symptoms, with or without urgency incontinence, usually with frequency and nocturia and severely affects the quality of life. This systematic review evaluates the various drug delivery strategies used in practice to manage OAB. Advanced drug delivery strategies alongside traditional strategies were comprehensively analysed and comparatively evaluated. The present review was conducted according to the preferred reporting items for systematic reviews and meta-analyses guidelines. A total of 24 studies reporting the development of novel formulations for the treatment of OAB were considered eligible and were further categorised according to the route of drug administration. The review found that various drug delivery routes (transdermal, intravesicular, oral, vaginal and intramuscular) are used for the administration of drugs for managing OAB, however, the outcomes illustrated the marked potential of transdermal drug delivery route. The findings of the current review are expected to be helpful for pharmaceutical scientists to better comprehend the existing literature and challenges and is anticipated to provide a basis for designing and fabricating novel drug delivery systems to manage OAB.Keywords
Funding Information
- University of Huddersfield (PHM112)
This publication has 88 references indexed in Scilit:
- Pathophysiology of Overactive BladderLUTS: Lower Urinary Tract Symptoms, 2012
- Prevalence of Overactive Bladder and Associated Risk Factors in 1359 Patients With Type 2 DiabetesUrology, 2011
- Urine and Serum C-Reactive Protein Levels as Potential Biomarkers of Lower Urinary Tract SymptomsUrological Science, 2010
- 1626 NON-INVASIVE IMAGING OF NEAR INFRAFRED DYE LABELED LIPOSOMES FACILITATES EVALUATION OF BIORESIDENCE TIMEJournal of Urology, 2010
- Patient‐reported reasons for discontinuing overactive bladder medicationBJU International, 2010
- Transdermal drug deliveryNature Biotechnology, 2008
- Developments in pharmacological therapy for the overactive bladderBJU International, 2006
- Pathophysiology of Overactive BladderThe American Journal of Medicine, 2006
- EFFECT OF INTRAVESICAL CAPSAICIN AND VEHICLE ON BLADDER INTEGRITY IN CONTROL AND SPINAL CORD INJURED RATSJournal of Urology, 1998
- The presence of mucosa reduces the contractile response of the guinea-pig urinary bladder to substance PJournal of Pharmacy and Pharmacology, 1987